Hiroaki Tanaka

6PUBLICATIONS
60CO-AUTHORS
Molecular targetsRegenerative medicine (incl. stem cells)International arbitrationAutoimmunityApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|May 18, 2026
Impact of trial exclusion criteria on real-world comparative effectiveness of targeted therapies in rheumatoid arthritis: the FIRST Registry.

|Feb 05, 2026
Real-world effectiveness of b/tsDMARD switching in low-inflammatory difficult-to-treat rheumatoid arthritis: insights from the FIRST registry.

Hidenori Sakai, Koshiro Sonomoto, Shingo Nakayamada

|Jan 16, 2026
Comparison of tofacitinib, baricitinib, upadacitinib and filgotinib: a 2-year observational study from FIRST registry.

Koshiro Sonomoto, Shingo Nakayamada, Hidenori Sakai

|Jan 03, 2025
Blood DNA virome associates with autoimmune diseases and COVID-19.

Noah Sasa, Shohei Kojima, Rie Koide

|Sep 17, 2024
Efficacy, safety and optimal intervention of belimumab for proliferative lupus nephritis patients in real-world settings: LOOPS registry.

Hidenori Sakai, Yusuke Miyazaki, Shingo Nakayamada

|Apr 18, 2024
A Machine Learning Approach for Prediction of CDAI Remission with TNF Inhibitors: A Concept of Precision Medicine from the FIRST Registry.

Koshiro Sonomoto, Yoshihisa Fujino, Hiroaki Tanaka

Pageof 1

Frequent Collaborators

6 joint publications

Yoshiya Tanaka

5 joint publications

Shingo Nakayamada

4 joint publications

Hidenori Sakai

4 joint publications

Masanobu Ueno